Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 8, 2021

View Archived Issues

Urinary follistatin useful to monitor AKI severity

Researchers develop a cystic fibrosis-related diabetes murine model

Roche describes new cyclic GMP-AMP synthase inhibitors

Janssen identifies NLRP3 inflammasome inhibitors

New GTPase KRAS mutant inhibitors discovered at Incyte

Aryl hydrocarbon receptor modulators discovered at Dong-A ST

New JAK inhibitors patented by Gossamer Bio

Mineralocorticoid receptor antagonism ameliorates DKD phenotype in mice

Viking Therapeutics' dual GLP-1/GIP receptor agonists show potential in model of obesity

Novel UOX-iKO mouse as model of hyperuricemia

RBT-9 shown effective against BK virus infection

STAR-0215, a potent and long-acting MAb plasma kallikrein inhibitor for the treatment of HAE

Analysis of lung phenotype in rat CF models using flexiVent and X-ray velocimetry

Novel small molecule K+ secretagogue RDX-013 for treating hyperkalemia

Antibody discovery platform increases cancer immunotherapy targets

Studies of KL-11743 detail potential oncolytic activity of glucose transporter inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...